trending Market Intelligence /marketintelligence/en/news-insights/trending/f58Obb2viRXIXi4HZmkKxg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Electromed reaches settlement with CMS on denied Medicare claims

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Electromed reaches settlement with CMS on denied Medicare claims

Electromed Inc. reached a settlement with Centers for Medicare and Medicaid Services, or CMS, regarding 700 Medicare fee-for-service claims.

The claims were submitted by the medical devices company between 2012 through 2015, and amount to approximately $2.9 million.

Electromed had previously requested an administrative law judge hearing for reconsidering the denied claims, the company said in an SEC filing June 5.

Under the settlement agreement, Electromed expects CMS to pay about $1.1 million to the company. The company, in exchange, will withdraw its request for the hearing and stop further appeal of the denial of claims.

Of the estimated $1.1 million the federal agency is to pay Electromed, $900,000 will be recognized as revenue during Electromed's fiscal quarter ended June 30.